Autopsy report · NCT02010203
A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT
Cause of deathRegulatory or ethics
“Inability to accrue due to changing treatment landscape (PD-1 approvals)”
Life of this trial
- Ran for about 4 years 4 months before it stopped.
- 104 participants enrolled.
- Results were posted on the registry 1 year 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Heat Biologics
- Sponsor type
- Industry
- Conditions
- Bladder Cancer
- Interventions
- HS-410; Placebo; BCG
- Participants
- 104
- Sites
- 19
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.